Phase I trial of motexafin gadolinium (MGd) and docetaxel administered at 3-week intervals for advanced solid tumours
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Motexafin gadolinium (Primary) ; Docetaxel
- Indications Advanced breast cancer; Non-small cell lung cancer; Ovarian cancer; Prostate cancer; Sarcoma
- Focus Adverse reactions
- Sponsors Pharmacyclics
- 14 May 2007 Status changed from in progress to completed.
- 24 Sep 2005 New trial record.